199 related articles for article (PubMed ID: 9845376)
21. Anti-GD3 monoclonal antibody analysis of childhood T-cell acute lymphoblastic leukemia: detection of a target antigen for antibody-mediated cytolysis.
Reaman GH; Taylor BJ; Merritt WD
Cancer Res; 1990 Jan; 50(1):202-5. PubMed ID: 2403416
[TBL] [Abstract][Full Text] [Related]
22. Utilization of two different T cell receptors by T cell acute lymphoblastic lymphoma and leukemia.
Gouttefangeas C; Bensussan A; Boumsell L
Nouv Rev Fr Hematol (1978); 1990; 32(5):337-40. PubMed ID: 2099407
[TBL] [Abstract][Full Text] [Related]
23. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
24. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
Kozlov I; Beason K; Yu C; Hughson M
Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
[TBL] [Abstract][Full Text] [Related]
25. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
26. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
27. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
28. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
29. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
[TBL] [Abstract][Full Text] [Related]
30. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies.
Robak T; Korycka A
Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133
[TBL] [Abstract][Full Text] [Related]
31. Aberration antigen expression in adult acute myelocytic leukemias.
Chen SS; Zhang HF; Xue WT; Li K; Fu JF; Wang DB; Wu PN
Chin Med J (Engl); 1993 Jun; 106(6):419-22. PubMed ID: 8222892
[TBL] [Abstract][Full Text] [Related]
32. [Classification of acute leukemias according to the first latin-american consensus conference for the immunophenotyping of leukemias].
Piedras J; Barrales-Benítez O; López-Karpovitch X
Rev Invest Clin; 2000; 52(5):524-8. PubMed ID: 11195181
[TBL] [Abstract][Full Text] [Related]
33. Specificity of heteroantisera to human acute leukemia-associated antigens.
Baker MA; Ramachandar K; Taub RN
J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
Aota F; Chang D; Hill NO; Khan A
Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147
[TBL] [Abstract][Full Text] [Related]
35. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
Ball ED; Kadushin JM; Schacter B; Fanger MW
J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
[TBL] [Abstract][Full Text] [Related]
36. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
37. [Monoclonal antibodies in diagnosis of acute leukemias].
Krawczyńska A; Robak T
Przegl Lek; 1996; 53(1):20-5. PubMed ID: 8711170
[TBL] [Abstract][Full Text] [Related]
38. Shifts in expression of immunological cell markers in relapsed acute leukemia.
Tomová A; Babusíková O
Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
[TBL] [Abstract][Full Text] [Related]
39. Single step immunophenotyping of acute leukemias not classifiable by standard morphology and cytochemistry: a practical approach.
Raimondi R; Pellizzari G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):66-72. PubMed ID: 8039763
[TBL] [Abstract][Full Text] [Related]
40. Expression of cytokine receptors on different myeloid leukemic cells.
Koubek K; Kumberová A; Starý J; Babusíková O; Klamová H; Filipec M
Neoplasma; 1998; 45(4):198-203. PubMed ID: 9890661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]